RefWorks

Oxford University

Simon Hunt's references on immune responses in lysosomal storage diseases

These references are not a systematic or comprehensive collection! Rather, they represent papers that interested me when trying to understand underlying mechanisms of antibody production in LSDs and how it might be modulated. You're strongly encouraged to post your comments and annotations on these research papers.


References to Use
Title
Atypical immunologic response in a patient with CRIM-negative Pompe disease
Source
Mol.Genet.Metab., 2011, 104, 4, 583-586
Folders
  Immune Responses in LSDs
Ref ID
1271Journal Article Reference 2 of 57
Title
Extending Serum Half-life of Albumin by Engineering Neonatal Fc Receptor (FcRn) Binding
Source
Journal of Biological Chemistry, 2014, 289, 19, 13492-13502
Folders
  Immune Responses in LSDs
Ref ID
499Journal Article Reference 3 of 57
Title
Effect of enzyme replacement therapy on gammopathies in Gaucher disease
Source
Blood Cells Mol.Dis., 32, 1, 214-217
Folders
  Immune Responses in LSDs
Ref ID
529Journal Article Reference 4 of 57
Title
Predicting cross-reactive immunological material (CRIM) status in Pompe disease using GAA mutations: Lessons learned from 10 years of clinical laboratory testing experience
Source
American Journal of Medical Genetics Part C: Seminars in Medical Genetics, 2012, 160C, 1, 40-49, Wiley Subscription Services, Inc., A Wiley Company
Folders
  Immune Responses in LSDs
Title
The impact of antibodies on clinical outcomes in diseases treated with therapeutic protein: Lessons learned from infantile Pompe disease
Source
Genetics in Medicine, 2011, 13, 8, 729-736
Folders
  Immune Responses in LSDs
Title
Characterization and quantitation of aggregates and particles in interferon-ß products: Potential links between product quality attributes and immunogenicity
Source
J.Pharm.Sci., 2013, 102, 3, 915-928
Folders
  Immune Responses in LSDs
Authors
Title
Therapy for lysosomal storage disorders
Source
IUBMB Life, 2010, 62, 1, 33-40
Folders
  Immune Responses in LSDs
Authors
Title
Immune response to enzyme replacement therapy in lysosomal storage disorder patients and animal models
Source
Mol.Genet.Metab., 1999, 68, 2, 268-275
Folders
  Immune Responses in LSDs
Ref ID
538Journal Article Reference 9 of 57
Title
Choreography of cell motility and interaction dynamics imaged by two-photon microscopy in lymphoid organs
Source
Annu.Rev.Immunol., 2008, 26, 585-626
Folders
  Immune Responses in LSDs
Title
Induction of immunological tolerance by oral anti-CD3
Source
Clin.Dev.Immunol., 2012, 2012
Folders
  Immune Responses in LSDs
Title
Immunogenicity of protein therapeutics
Source
Trends Immunol., 2007, 28, 11, 482-490
Folders
  Immune Responses in LSDs
Authors
Title
Fabry disease, enzyme replacement therapy and the significance of antibody responses
Source
J.Inherit.Metab.Dis., 2012, 35, 2, 227-243
Folders
  Immune Responses in LSDs
Authors
Title
Pharmacokinetics and pharmacokinetic-pharmacodynamic correlations of therapeutic peptides
Source
Clin.Pharmacokinet., 2013, 52, 10, 855-868
Folders
  Immune Responses in LSDs
Authors
Title
Genomic medicine: New therapeutic approaches to mendelian disorders
Source
N.Engl.J.Med., 2010, 363, 9, 852-863
Folders
  Immune Responses in LSDs
Ref ID
536Journal Article Reference 15 of 57
Title
Decoration of T-independent antigen with ligands for CD22 and Siglec-G can suppress immunity and induce B cell tolerance in vivo
Source
J.Exp.Med., 2010, 207, 2, 445-445
Folders
  Immune Responses in LSDs
Authors
Title
The challenge of immunogenicity in the quest for induced pluripotency
Source
Nature Reviews Immunology, 2010, 10, 12, 868-875
Folders
  Immune Responses in LSDs
Title, Primary
Aggregation and Immunogenicity of Therapeutic Proteins
Source
Folders
  Immune Responses in LSDs
Title
Immunoglobulin and free light chain abnormalities in Gaucher disease type I: Data from an adult cohort of 63 patients and review of the literature
Source
Ann.Hematol., 2008, 87, 6, 439-449
Folders
  Immune Responses in LSDs
Ref ID
539Journal Article Reference 19 of 57
Title
Screening patients referred to a metabolic clinic for lysosomal storage disorders
Source
Journal of Medical Genetics, 2011, 48, 6, 422-425
Folders
  Immune Responses in LSDs
Title
Production platforms for biotherapeutic glycoproteins. Occurrence, impact, and challenges of non-human sialylation
Source
Biotechnol.Genet.Eng.Rev., 2012, 28, 147-175
Folders
  Immune Responses in LSDs
Title
Gaucher disease and monoclonal gammopathy: A report of 17 cases and impact of therapy
Source
Blood Cells Mol.Dis., 2009, 43, 1, 138-139
Folders
  Immune Responses in LSDs
Authors
Title
Perspectives from B cell immunology: Fact and fancy
Source
Int.J.Clin.Pharmacol.Ther., 2009, 47, SUPPL. 1, S86-S99
Folders
  Immune Responses in LSDs
Ref ID
1301Generic Reference 23 of 57
Authors, Primary
Title, Primary
Immunogenicity of Therapeutic Fusion Proteins: Contributory Factors and Clinical Experience
Folders
  Immune Responses in LSDs
Authors, Primary
Title, Primary
Immunogenicity of Therapeutic Fusion Proteins: Contributory Factors and Clinical Experience
Folders
  Immune Responses in LSDs
Title
T-cell dependent immunogenicity of protein therapeutics: Preclinical assessment and mitigation
Source
Clin.Immunol., 2013, 149, PB, 534-555
Folders
  Immune Responses in LSDs
Close

View ReferenceView ReferenceCreate BibliographyCreate BibliographyCreate Bibliography
ExportExportExport
Add to My ListAdd to My ListRemove from My ListRemove from My List
Create BibliographyCreate BibliographyCreate Bibliography
ExportExportExport
FOLDERDuplicatesFind Duplicates
Exact Duplicates in this FolderClose Duplicates in this Folder Exact Duplicates in All ReferencesClose Duplicates in All References
FOLDERSharingSharing
Remove ShareRemove Share
Share FolderShare FolderShare LinkRemove ShareRemove ShareShared Folder OptionsShared Folder OptionsEmail this shareEmail this share
FOLDERSearchSearchCreate BibliographyCreate BibliographyCreate BibliographyExportExportExport
View Shared AreaView Shared AreaView RSS FeedView RSS FeedEmail RefShare OwnerEmail RefShare OwnerShare FolderShare FolderShare Link